期刊文献+

甲状腺癌分化转移与外周血相关mi RNA表达水平的相关性研究

Correlation between thyroid carcinoma differentiation and metastasis and miRNA expression levels in peripheral blood
在线阅读 下载PDF
导出
摘要 目的研究甲状腺癌分化转移与外周血相关微小核糖核(microRNA,miRNA)表达水平的相关性。方法从本院2018年-2021年间经病理诊断检确诊为乳头状甲状腺癌患者中选择48例转移的乳头状甲状腺癌患者作为研究组(乳头状甲状腺癌25例、甲状腺髓样癌5例、滤泡型甲状腺癌12例,未分化甲状腺癌6例),另选择未转移的48例乳头状甲状腺癌患者作为对照组(乳头状甲状腺癌25例、甲状腺髓样癌4例、滤泡型甲状腺癌13例,未分化甲状腺癌6例)。收集两组患者的血清,检测两组患者血清中的miRNA-221、miRNA-222、miRNA-146b、miRNA-21、miRNA125b、miRNA-181a的表达水平。收集两组患者的病变组织,应用免疫组织化学的方法检测N-cadherin、MMP9的表达水平。结果在本研究中,研究组患者血清中的mi RNA-221、miRNA-222表达水平显著高于对照组(P<0.05);研究组患者与对照组患者之间miRNA-146b、miRNA-21差异不显著(P>0.05);对照组患者血清中的miRNA-125b的表达水平显著高于研究组(P<0.05),研究组患者血清中的miRNA-181a表达水平显著低于对照组患者(P<0.05);研究组患者N-cadherin、MMP9阳性率显著高于对照组(P<0.05)。结论在判断甲状腺癌肿瘤的分化转移与预后中,应用检测血清中miRNA水平的方法具有较高的应用价值,为医生确定治疗方案、做出诊断提供了有效的信息。 Objective To investigate the correlation between the differentiation and metastasis of thyroid cancer and the expression level of micro RNA(mi RNA).Methods 48 patientswho were diagnosed with transferred papillary thyroid carcinoma in our hospital from 2018 to 2021 were chosen as the research group including 25 cases with papillary thyroid carcinoma,5 cases with medullary thyroid carcinoma,12 cases with follicular thyroid carcinoma and 6 caseswith undifferentiated thyroid carcinoma.48 patients with unmetastatic papillary thyroid carcinoma were selected as the control group including 25 cases of papillary thyroid carcinoma,4 cases of medullary thyroid carcinoma,13 cases of follicular thyroid carcinoma and 6 undifferentiated thyroid carcinoma.Serum from both groups were collected and the expression levels of mi RNA-221,mi RNA-222,mi RNA-146b,mi RNA-21,mi RNA125b,and mi RNA-181a were measured.Lesional tissues were collected from both groups,and the expression levels of N-cadherin and MMP9were determined by immunohistochemistry method.Results In this study,miRNA-221 and miRNA-222 expression levels in the research group were significantly higher than that of the control group(P<0.05).miRNA-146b and miRNA-21 had no significant differences between two groups(P>0.05).miRNA-125 bin control group was significantly higher than that in study group(P<0.05).miRNA-181a in study group was significantly lower than that of control patients(P<0.05).The positive rate of N-cadherin and MMP9was significantly higher than that of control group(P<0.05).Conclusion Detection of serum mi RNA levels has a high application value in determing the differentiation,metastasis and prognosis of thyroid cancer,which provides effective information for doctors to determine the treatment plan and make diagnosis.
作者 王志勇 WANGZhiyong(Hemei Hospital of Shangqiu,Henan,Shangqiu,476000,China)
机构地区 商丘和美医院
出处 《新疆医学》 2022年第8期887-890,共4页 Xinjiang Medical Journal
关键词 甲状腺癌 肿瘤的分化转移 MIRNA 免疫组化 Thyroid cancer Differentiation and metastasis of tumor mi RNA Immunohistochemistry
作者简介 王志勇,男,主治医师,研究方向:普通外科学。
  • 相关文献

参考文献14

二级参考文献85

  • 1申桂华,张毅.卵巢上皮性癌中p53和VEGF表达的相互关系及其临床意义[J].中国肿瘤临床与康复,2006,13(3):209-211. 被引量:2
  • 2SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics,2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
  • 3HAUGEN B R, ALEXANDER E K, BIBLE K C, et al. 2015 American Thyroid Association management guidelines for adultpatients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2015. [Epub ahead of print].
  • 4SAMPSON E, BRIERLEY J D, LE L W, et al. Clinicalmanagement and outcome of papillary and follicular(differentiated) thyroid cancer presenting with distantmetastasis at diagnosis[J]. Cancer, 2007, 110(7): 1451-1456.
  • 5GUPTA M, GUPTA S, GUPTA V B. Correlation of fine needleaspiration cytology with histopathology in the diagnosis ofsolitary thyroid nodule[J]. J Thyroid Res, 2010: 379051.
  • 6CIBAS E S, ALI S Z. The Bethesda system for reportingthyroid cytopathology[J]. Thyroid, 2009, 19(11): 1159-1165.
  • 7YIP L. Molecular markers for thyroid cancer diagnosis,prognosis, and targeted therapy[J]. J Surg Oncol, 2015,111(1): 43-50.
  • 8LI F, CHEN G, SHENG C, et al. BRAFV600E mutation inpapillary thyroid microcarcinoma: a meta-analysis[J].Endocr Relat Cancer, 2015, 22(2): 159-168.
  • 9KIM T H, PARK Y J, LIM J A, et al. The association of theBRAF(V600E) mutation with prognostic factors and poorclinical outcome in papillary thyroid cancer: a meta-analysis[J]. Cancer, 2012, 118(7): 1764-1773.
  • 10BAZANOVA N V, SE?TS I F. Can the presence of an RNAlipoproteincomplex in human blood serum give evidence of acancerous disease?[J]. Eksp Onkol, 1989, 11(2): 37-39.

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部